Obiettivo
A number of nanomedicine formulations have enabled, or been shown to hold considerable potential for enabling more effective and less toxic therapeutic interventions. However, progress to date in translating these initiatives to commercial success has been limited. One of the main reasons for this bottleneck is due to the inability of researchers and stakeholders to manufacture batches of the nanomedicine product at the required scale and according to Good Manufacturing Practice (GMP) requirements. The NANOFACTURING project will focus on
- facilitating access to required infrastructures and expertise
- creating GMP pilot lines for up-scaling manufacturing
- addressing the current developmental and production gaps
- taking nanomaterials already successfully produced at proof-of-concept/milligram levels and facilitating their scale-up to sub-kilogram quantities
- providing large-scale and GMP production for clinical trials and nanomedicine translation.
The NANOFACTURING project, through a consortium of 9 partners, will develop the synthetic processes, process control methods, analytical assays for QA/QC, functional specifications, and best practices, interfacing existing R&D centres of excellence, transfer organisations and private GMP manufacturing facilities (including SMEs) to ensure efficient translation from discovery through to first in man, proof-of-concept studies and beyond to Phase III according to industrial and regulatory standards. Specifically, the NANOFACTURING project aims to create a platform process for early, mid- and large-scale manufacturing of glycan-coated gold nanoparticles (GNPs), a widely researched and developed class of self-forming nanoparticles. The ability to engineer new nanopharmaceuticals based on this patent protected platform technology, developed by Midatech Biogune S.L. (Project Coordinator), will have inherent advantages over existing treatments for multiple therapeutic areas.
Campo scientifico
- scienze naturaliscienze fisicheotticamicroscopiaelectron microscopy
- scienze mediche e della salutebiotecnologia medicananomedicina
- scienze mediche e della salutemedicina clinicaoncologia
- scienze mediche e della salutemedicina di basefarmacologia e farmaciafarmacocinetica
- ingegneria e tecnologiananotecnologiananomateriali
Programma(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-NMP-PILOTS-2014
Meccanismo di finanziamento
RIA - Research and Innovation actionCoordinatore
48160 Derio
Spagna
Mostra sulla mappa
Partecipanti (9)
TS10 4RF Redcar Cleveland
Mostra sulla mappa
81823 Sopot
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
15822 Touro A Coruna
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
CF24 0AA Cardiff
Mostra sulla mappa
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.
4 Dublin
Mostra sulla mappa
08193 Cerdanyola Del Valles Barcelona
Mostra sulla mappa
Partecipazione conclusa
20139 Milano
Mostra sulla mappa
1015 Lausanne
Mostra sulla mappa
70126 Bari
Mostra sulla mappa